Welcome to our dedicated page for Corvex SEC filings (Ticker: MOVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Movano Inc. (Nasdaq: MOVE) SEC filings page on Stock Titan provides direct access to the company’s official regulatory disclosures, along with AI-powered summaries that help explain their contents in plain language. Movano, doing business as Movano Health, files a range of documents with the U.S. Securities and Exchange Commission that together outline its wearable health technology business, capital structure, and significant corporate events.
Investors can review registration statements such as the Form S-1 that describes a committed equity facility with Chardan Capital Markets LLC, including the potential issuance of up to 110,000,000 shares of common stock under the facility and Movano’s status as an emerging growth company and smaller reporting company. The S-1 and related materials also discuss Nasdaq listing matters, reverse stock split effects on share counts, and stockholders’ equity considerations.
Current reports on Form 8-K document material events, including the Agreement and Plan of Merger with Corvex, Inc., the structure of the all-stock combination, expected ownership percentages of the combined company, and conditions to closing. Other 8-K filings cover the one-for-ten reverse stock split, Nasdaq deficiency notices and extensions, amendments to incentive plans, preferred stock financings, amendments to loan agreements, and stockholder meeting results. These filings provide detail on how Movano is addressing listing requirements, financing needs, and its planned transformation through the Corvex merger.
Definitive proxy statements on Schedule 14A offer insight into stockholder votes on matters such as increasing authorized share capital, approving share issuances under the ChEF Purchase Agreement, amending the omnibus incentive plan, and authorizing reverse stock splits. They also describe virtual special meeting logistics and voting procedures for common and preferred stockholders.
On Stock Titan, each filing is accompanied by AI-generated highlights that point out key terms, risk factors, and structural details, helping users navigate lengthy documents like S-1 registration statements and complex 8-K merger disclosures. The platform also makes it easier to locate quarterly and annual reports when filed (Forms 10-Q and 10-K), as well as any insider transaction reports on Form 4, so users can monitor executive and director share dealings once available.
By using this page, investors can quickly find Movano’s official SEC filings related to its wearable medical devices, financing arrangements, Nasdaq compliance efforts, and the proposed renaming and repositioning of the company as Corvex, Inc. after the merger closes, while relying on AI tools to surface the most important information from each document.
Movano Inc. received a notice of proposed sale on Form 144 covering planned sales of its Class A common stock. The filing indicates a plan to sell 21,000 shares of Class A common stock on the NYSE through J.P. Morgan Securities LLC, with an aggregate market value of $150,000 and 834,857 shares of this class shown as outstanding. The approximate sale date listed is 01/07/2026.
The securities to be sold were acquired from Movano Inc. via a cashless option exercise and sale transaction dated 11/03/2025, with 42,250 common shares acquired and cash payment dated 01/08/2026. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about Movano’s current or prospective operations.
Movano Inc. is registering an additional 500,000 shares of common stock under its Amended and Restated 2019 Omnibus Incentive Plan. The increase reflects an amendment to the 2019 Plan approved by stockholders on December 16, 2025 at a special meeting, expanding the number of shares available for equity-based awards to employees, directors and other eligible participants. These shares are the same class as those previously registered on earlier Form S-8 filings, and the company incorporates those prior registrations and its latest annual and quarterly reports by reference.
Movano Inc. has filed a resale prospectus covering up to 110,000,000 shares of common stock that may be sold from time to time by Chardan Capital Markets under a committed equity facility. Movano is not selling shares in this prospectus and will not receive proceeds from Chardan’s resales, but it may receive up to $1,000,000,000 in gross proceeds from primary share sales to Chardan under a separate purchase agreement.
As of September 30, 2025, Movano had 834,908 common shares outstanding, and the offering table shows 869,276 shares outstanding before this facility and 110,869,276 assuming full issuance, illustrating substantial potential dilution. The equity line is subject to Nasdaq’s 19.99% exchange cap, a 4.99% beneficial ownership cap for Chardan, and Corvex’s prior written consent before the planned merger closing. Movano has agreed to merge with AI cloud company Corvex, expects closing in the first quarter of 2026, and is currently working to regain Nasdaq stockholders’ equity compliance by March 30, 2026 after reporting negative equity.
Movano Inc. filed an update to reflect a previously completed one-for-ten reverse stock split of its common stock, effective as of October 10, 2025. Each ten pre-split shares of common stock were automatically combined into one new share, reducing the number of outstanding shares from approximately 8.3 million to approximately 0.8 million. The reverse split did not change the number of authorized shares or the par value of the stock.
The company is republishing its audited consolidated financial statements for the years ended December 31, 2024 and December 31, 2023 to reflect the new share count. Aside from adjusting for the share consolidation, the underlying financial statements remain unchanged.
Movano Inc. filed an update explaining the impact of its previously completed one-for-ten reverse stock split of its common stock, which became effective on October 10, 2025. Each ten pre-split shares were combined into one new share, reducing the number of outstanding common shares from approximately 8.3 million to approximately 0.8 million. The reverse split did not change the total number of authorized common shares or the par value per share.
The company is republishing its audited consolidated financial statements for the years ended December 31, 2024 and December 31, 2023 to reflect the revised share count resulting from the reverse split. Aside from adjusting for the new number of shares outstanding, no other changes were made to those financial statements. A consent from Baker Tilly US, LLP and the updated financial statements are included as exhibits.
Movano Inc. reported the results of a special stockholder meeting held on December 16, 2025. Stockholders approved, for Nasdaq Listing Rule 5635(d) purposes, the potential issuance of more than 20% of the company’s issued and outstanding common shares under a ChEF Purchase Agreement with Chardan Capital Markets, LLC, with votes of 252,589 for, 2,088 against and 2,144 abstaining, plus 269,643 broker non-votes. They also approved a Certificate of Amendment to increase authorized common shares from 500,000,000 to 2,500,000,000, with 500,623 for, 23,285 against and 2,556 abstaining. In addition, stockholders approved Amendment No. 3 to the 2019 Omnibus Incentive Plan and authorized potential adjournment of the meeting if needed, both by wide margins.
Movano Inc. reported that on December 16, 2025, stockholders approved several proposals at a special meeting that significantly expand its ability to issue equity.
Stockholders approved issuing more than 20% of the company’s issued and outstanding common shares under a ChEF Purchase Agreement with Chardan Capital Markets, LLC, as required by Nasdaq Listing Rule 5635(d). They also approved increasing authorized common stock from 500,000,000 to 2,500,000,000 shares and adopted Amendment No. 3 to the 2019 Omnibus Incentive Plan. In addition, stockholders approved the possible adjournment of the special meeting to permit further solicitation of proxies if necessary.
Movano Inc. is asking stockholders to approve four proposals at a special virtual meeting on December 16, 2025. The first would permit issuing more than 166,887 shares under a committed equity facility with Chardan, which allows Movano to sell up to $1,000,000,000 of common stock over 36 months, potentially at a discount to market, in order to access capital as needed.
The second proposal would amend the certificate of incorporation to increase authorized common stock from 500,000,000 to 2,500,000,000 shares, significantly expanding capacity for future financings, acquisitions, and other corporate uses. The third proposal would add 500,000 shares to the 2019 Incentive Plan, enabling previously granted discounted stock options and future equity awards to employees, executives, and directors. The fourth proposal would allow adjournment of the meeting to gather additional proxies if required.
Movano Inc. (MOVE) called a special stockholder meeting to vote on four items affecting capital access and equity plans. Proposal 1 seeks approval to issue shares under a committed equity facility with Chardan (the “ChEF”) beyond Nasdaq’s 19.99% cap. The facility permits sales of common stock to Chardan for up to $1,000,000,000 in aggregate purchase price, subject to limits, including a 4.99% beneficial ownership cap. The company states the current Exchange Cap would otherwise restrict issuance to 166,887 shares at prices below $5.30 (“Nasdaq Minimum Price”).
Proposal 2 would amend the certificate of incorporation to increase authorized common stock from 500,000,000 to 2,500,000,000 shares (with total authorized capital adjusted accordingly). The Board cites flexibility for financings, acquisitions, compensation and other corporate purposes.
Proposal 3 would amend the 2019 Incentive Plan to add 500,000 shares, supporting previously granted, discounted options issued in lieu of cash compensation and one-time awards, all contingent on approval. Examples include contingent options at $1.25 expiring December 31, 2025. Proposal 4 authorizes adjournment of the meeting if needed. Common shares outstanding were 834,857 as of November 10, 2025; Series A Preferred were 3,000 shares, then convertible into 87,694 common shares.
Movano Inc. (MOVE) reported an insider equity change. On 11/03/2025, a director forfeited 12,442 previously awarded RSUs in lieu of directors’ fees and received a stock option for 55,250 shares at an exercise price of $1.25.
The option will become exercisable upon shareholder approval of an amendment increasing shares under the Omnibus Incentive Plan. Following the transactions, the director beneficially owned 2,690 common shares. The disclosed option lists an expiration date of 12/31/2025.